Gene · 131450
CD200R1: CD200 receptor 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CD200R1: CD200 receptor 1. Genes, record 131450. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/131450
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8TD46 | Cell surface glycoprotein CD200 receptor 1 | 348 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents29
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40488 | Q8TD46 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4728 | Q8TD46 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 2256 | Q8TD46 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4728 | Q8TD46 | Espacenet |
| EP 4526347 A1 | 2025-03-26 | 172 | Q8TD46 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 2256 | Q8TD46 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 2256 | Q8TD46 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 2263 | Q8TD46 | Espacenet |
| US 11761963 B2 | 2023-09-19 | 42 | Q8TD46 | Espacenet |
| US 11719707 B2 | 2023-08-08 | 13 | Q8TD46 | Espacenet |
1 to 10 of 29
See all 29 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants777
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CD200R1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016058 | Cancer Center Support Grant | 7 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 5 | 2025 |
| R01CA208353 | Elucidation of Human Natural Killer Cell Development | 4 | 2025 |
| ZIAAI001124 | Translational Research: Host-Pathogen Interactions in Patient Fungal Diseases | 4 | 2025 |
| P30AI045008 | Penn Center for AIDS Research | 3 | 2025 |
| R35CA210087 | Human natural killer cells: Advancing biology and clinical applications | 3 | 2025 |
| U19AI057229 | Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro | 3 | 2025 |
| ZIAAI001123 | Molecular Pathobiology of Cryptococcus neoformans | 3 | 2025 |
| P01CA018029 | Adult Leukemia Research Center | 2 | 2025 |
| P01CA225517 | Immunobiology and Immune Therapy for Merkel Cell Carcinoma | 2 | 2025 |
1 to 10 of 777Source NIH's project files
See all 777 nih grantsPapers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics Analysis of T-cell Exhaustion Genes in Pediatric Allergic Rhinitis and their Clinical Diagnostic Significance. | Endocr Metab Immune Disord Drug Targets | 2026 | 42813621 | PubTator, text mining | PubMed |
| Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200. | Front Oncol | 2026 | 42798844 | PubTator, text mining | PubMed |
| CD200-CD200R as a myeloid immune checkpoint in solid tumors: mechanisms, context-dependent functions, and therapeutic opportunities. | Front Immunol | 2026 | 42761652 | PubTator, text mining | PubMed |
| Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma. | Sci Transl Med | 2026 | 42715345 | PubTator, text mining | PubMed |
| Evaluation of the predictive value of sCD200 and sCD200R for disease severity and relapse in myasthenia gravis. | Clin Chim Acta | 2026 | 42700883 | PubTator, text mining | PubMed |
| CD200 is a potent new growth factor in Multiple Myeloma dependent on IGF1 receptor signaling. | Transl Oncol | 2026 | 42664786 | PubTator, text mining | PubMed |
| Retraction: Bone marrow mesenchymal stem cells alleviate smoke inhalation injury by regulating alveolar macrophage polarization via the CD200-CD200R pathway. | Front Immunol | 2026 | 42602831 | PubTator, text mining | PubMed |
| Radiation-induced CD200+ tumor-associated macrophages suppress eosinophil-mediated antitumor immunity through CD200R signaling in hepatocellular carcinoma. | Cell Mol Immunol | 2026 | 42595852 | PubTator, text mining | PubMed |
| Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer. | J Clin Invest | 2026 | 42390925 | PubTator, text mining | PubMed |
| CD200R protects against ulcerative colitis by regulating macrophage polarization and intestinal barrier function: evidence from human patients and mouse disease models. | Free Radic Biol Med | 2026 | 42349804 | PubTator, text mining | PubMed |
1 to 10 of 1,628
See all 1,628 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/131450
GET https://conductscience.org/api/genes/v1/131450/patents?page=2